Growth hormone treatment in a girl with Prader Willi syndrome.
Indian J Pediatr
; 70(4): 351-3, 2003 Apr.
Article
in En
| MEDLINE
| ID: mdl-12793314
ABSTRACT
Prader Willi syndrome (PWS) is a rare endocrine-metabolic disorder that is characterised by neonatal hypotonia, hyperphagia, marked obesity, short stature, hypogonadism and behavioural problems. 7-20% percent of these children develop diabetes mellitus. A large number of individuals with PWS show growth hormone (GH) deficiency. Recent studies indicate beneficial effects of GH replacement therapy not only for their linear growth but also for correction of metabolic dysfunction. In the present communication this article details about the therapeutic outcome in a girl with PWS who received recombinant growth hormone (rGH), Genotropin. Some carry-over therapeutic benefits have been observed even after discontinuation of rGH.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prader-Willi Syndrome
/
Recombinant Proteins
/
Human Growth Hormone
Type of study:
Diagnostic_studies
Limits:
Adolescent
/
Female
/
Humans
Language:
En
Journal:
Indian J Pediatr
Year:
2003
Document type:
Article